Med Page Today

DECEMBER 21, 2023

(MedPage Today) -- For patients undergoing catheter ablation for atrial fibrillation (Afib), there was no signal that a brief course of colchicine reduced atrial arrhythmia recurrence or improved clinical outcomes when taken for 10 days starting.

Arrhythmia 116

Arrhythmia Ablation Atrial Fibrillation AFIB 116

DAIC

APRIL 18, 2024

Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrial fibrillation ablation, Musat et al. However, this reasoning disregards valuable data regarding early arrhythmia recurrences and their potential significance.

Atrial Fibrillation 111

Atrial Fibrillation Ablation Heart Rhythm Article 111

DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

DAIC

MARCH 28, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTec h i , announced the submission of the VARIPULSE Platform for Premarket Approval Application (PMA) to the U.S. Twelve-month outcomes data from the pilot phase of the admIRE study, which assessed the safety and efficacy of the VARIPULSE Platform among U.S.

Atrial Fibrillation 110

Atrial Fibrillation AFIB Ablation Pulmonary 110

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2025

IntroductionAtrial fibrillation (AF) is a prevalent cardiac arrhythmia and a significant contributor to cardioembolic stroke, a condition closely linked to cognitive decline. However, research reveals that AF itself is independently associated with an increased risk of cognitive impairment.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Arrhythmia Research 52

Frontiers in Cardiovascular Medicine

JANUARY 16, 2024

Introduction Catheter ablation is an effective and safe strategy for treating atrial fibrillation patients. Nevertheless, studies on the long-term outcomes of catheter ablation in patients with dilated cardiomyopathy are limited. Among the catheter ablation group, 58.7% ( n  = 27) had persistent atrial fibrillation.

Atrial Fibrillation 64

Atrial Fibrillation Ablation Cardiomyopathy Heart Failure 64

Cardiomatics

APRIL 5, 2024

By understanding the nuances of abnormalities detected in Cardiomatics and interpreting detailed reports, healthcare professionals can intervene promptly to prevent adverse outcomes. AFIB/AFL – atrial fibrillation or atrial flutter episodes. 1] Arrhythmia Recognition: The Art of Interpretation, T.Garcia, D.Garcia.

Arrhythmia 92

Arrhythmia Tachycardia Bradycardia Electrocardiogram 92

Frontiers in Cardiovascular Medicine

JULY 31, 2024

Atrial fibrillation (AF) represents the most common cardiac arrhythmia with significant morbidity and mortality implications. This review aims to analyze the existing literature on the effects of dietary modifications on the incidence, progression, and outcomes of atrial fibrillation.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Diet Arrhythmia 52

HeartRhythm

APRIL 30, 2024

Atrial fibrillation is the most common sustained arrhythmia. Females with atrial fibrillation have been known to have an increased risk of stroke. However, racial disparities in outcomes in atrial fibrillation patients have been less studied.

Atrial Fibrillation 40

Atrial Fibrillation Outcomes Hospital Arrhythmia 40

Frontiers in Cardiovascular Medicine

JANUARY 31, 2024

Background Pulmonary vein isolation with wide antral ablation leads to better clinical outcomes for the treatment of atrial fibrillation, but the isolation lesion is invisible in conventional cryoballoon ablation. The rate of 12-month freedom from clinical atrial arrhythmia recurrence was 85.1% min, P  = 0.177).

Atrial Fibrillation 64

Atrial Fibrillation Ablation Pulmonary Outcomes 64

Open Heart

JANUARY 18, 2024

Introduction Three recent randomised controlled trials have demonstrated that pulmonary vein isolation as an initial rhythm control strategy with cryoablation reduces atrial arrhythmia recurrence in patients with symptomatic paroxysmal atrial fibrillation (PAF) compared with antiarrhythmic drug (AAD) therapy.

Atrial Fibrillation 69

Atrial Fibrillation Ablation Pulmonary Arrhythmia 69

HeartRhythm

APRIL 30, 2024

Atrial fibrillation (AF) is the most common arrhythmia in clinical practice and accounts for many arrhythmia-related hospitalizations. Despite being on anticoagulation (AC), male patients with atrial fibrillation have worse inpatient outcomes compared to females.

Atrial Fibrillation 40

Atrial Fibrillation Inpatient Outcomes Arrhythmia 40

Frontiers in Cardiovascular Medicine

DECEMBER 14, 2023

Typical atrial flutter commonly occurs in patients with atrial fibrillation (AF). Limited information exists regarding the effects of concurrent atrial flutter on the long-term outcomes of rhythm control. Patients who were screened for typical atrial flutter were included in the analysis ( n  = 1,907).

Atrial Flutter 64

Atrial Flutter Atrial Fibrillation Ablation Arrhythmia 64

Frontiers in Cardiovascular Medicine

OCTOBER 9, 2024

The primary outcome was ventricular arrhythmias, the secondary outcomes were bradycardia and atrial fibrillation (AF).ResultsOur Perioperative or postoperative use of DEX reduced the incidence of in-hospital ventricular arrhythmias [Odds Ratio (OR) 0.14, 95% Confidence Interval (CI) 0.03–0.66],

Arrhythmia 52

Arrhythmia Bradycardia Atrial Fibrillation Hospital 52

American College of Cardiology

FEBRUARY 19, 2025

In this weeks View, Dr. Eagle looks at arrhythmia recurrence and rhythm control after catheter ablation for atrial fibrillation. He then discusses long-term outcomes in transthyretin amyloid cardiomyopathy in patients treated with tafamidis.

Arrhythmia 51

Arrhythmia Cardiomyopathy Ablation AFIB 51

DAIC

FEBRUARY 2, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , revealed findings from a company-funded study of real-world data. AFib is the most common type of cardiac arrhythmia and affects more than 6 million people in the United States and nearly 38 million people worldwide.2,3 In: AF Symposium.;

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

HeartRhythm

APRIL 30, 2024

The introduction of Bruton Tyrosine Kinase inhibitors (BTKi) to the Chronic Lymphocytic Leukemia (CLL) treatment armamentarium has facilitated a significant improvement in overall outcomes. Incident atrial fibrillation (AF) has been identified as the most common reason for discontinuation of BTKi, limiting therapeutic utility of these agents.

Atrial Fibrillation 40

Atrial Fibrillation Arrhythmia Stroke Strokes 40

HeartRhythm

APRIL 7, 2024

Atrial fibrillation (AF), already the most prevalent clinical arrhythmia, is increasing in prevalence1. It is associated with adverse outcomes that significantly impact the quality of life (QoL) experienced by patients. Patient-reported outcomes (PROs) are now commonly used to evaluate QoL in clinical trials3.

Atrial Fibrillation 40

Atrial Fibrillation Quality of Life Outcomes Arrhythmia 40

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Background Catheter ablation (CA) for symptomatic atrial fibrillation (AF) offers the best outcomes for patients. The probability of freedom from atrial arrhythmia with repeat procedures is as follows: year 1: 0.95, year 2: 0.92, year 3: 0.85, year 4: 0.79, and year 5: 0.72. Age >75 years ( p  = 0.02, HR: 2.7,

Ablation 64

Ablation Atrial Fibrillation BMI Arrhythmia 64

HeartRhythm

APRIL 30, 2024

Atrial Fibrillation (AF) is the most common arrhythmia associated with hospital admissions in the United States. Recent guidelines advocate for early rhythm control in this population, however, there is little information regarding early electrophysiologist intervention and resulting patient outcomes.

Atrial Fibrillation 40

Atrial Fibrillation Hospital Outcomes Arrhythmia 40

Cardiovascular Diabetology

FEBRUARY 23, 2024

Objective We aimed to assess the effect of SGLT2i on arrhythmias by conducting a meta-analysis using data from randomized controlled trials(RCTs). Background Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have shown cardioprotective effects via multiple mechanisms that may also contribute to decrease arrhythmias risk.

Sudden Cardiac Death 64

Sudden Cardiac Death Arrhythmia Atrial Flutter Heart Failure 64

HeartRhythm

APRIL 30, 2024

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Catheter ablation (CA) has emerged as an important modality for managing AF, improving quality of life, and potentially reversing cardiac dysfunction.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Quality of Life Arrhythmia 40

European Journal of Heart Failure

FEBRUARY 25, 2025

Overview of the study population and effects observed after catheter ablation for atrial fibrillation. Herein we describe the effects of catheter ablation on AF burden, arrhythmia recurrences, and ventricular function in end-stage HF. PVI, pulmonary vein isolation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Arrhythmia 40

HeartRhythm

JANUARY 6, 2025

Atrial fibrillation (AF) is a common arrhythmia in patients with heart failure (HF). The coexistence of these conditions can further induce structural changes and result in worsened outcomes such as stroke, HF decompensation, poorly controlled AF, and mortality [1].

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

AUGUST 13, 2024

Atrial arrhythmias (AA), particularly atrial fibrillation (AF), are prevalent in CA and may impact long-term cardiovascular outcomes, prompting an investigation into early rhythm management strategies.2 1 Recent advancements in imaging and therapeutic agents have sparked considerable interest in this field.

Arrhythmia 40

Arrhythmia Ablation Atrial Fibrillation Outcomes 40

Frontiers in Cardiovascular Medicine

FEBRUARY 7, 2024

Background Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with a high risk of stroke. Conclusion Our findings indicate that an enlarged left atrium and abnormal hemodynamic parameters in the left atrial and pulmonary veins are linked to a greater risk of LAT/SEC.

Atrial Fibrillation 64

Atrial Fibrillation Stroke Strokes Pulmonary 64

Journal of Cardiovascular Electrophysiology

NOVEMBER 11, 2024

This study of 16 patients with persistent left superior vena cava (PLSVC) undergoing atrial fibrillation ablation shows a 66.7% recurrence rate signals the need for enhanced outcomes in this challenging population. The recurrence rate of arrhythmia postablation was 46.7% However, a 46.7% No major complications occurred.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Pulmonary 40

HeartRhythm

DECEMBER 11, 2024

Asthma is a known risk factor for atrial fibrillation (AF), the most common sustained arrhythmia. While radiofrequency catheter ablation is effective in treating AF, the impact of asthma and its severity on ablation outcomes has not been previously explored.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Risk Factors Arrhythmia 40

Circulation: Arrhythmia and Electrophysiology

DECEMBER 19, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Pulsed field ablation (PFA) is a promising treatment for atrial fibrillation. One-year freedom from atrial arrhythmia was 80.2% (95% CI, 69.7%87.4%) One-year freedom from atrial arrhythmia was 80.2% (95% CI, 69.7%87.4%)

Atrial Fibrillation 40

Atrial Fibrillation Ablation Arrhythmia Outcomes 40

HeartRhythm

SEPTEMBER 12, 2024

Traumatic brain injury (TBI) is associated with a variety of adverse long-term outcomes and increases sympathetic nervous system activation which could increase the risk of arrhythmias including atrial fibrillation or atrial flutter (AF/AFL).

Atrial Flutter 40

Atrial Flutter Atrial Fibrillation Arrhythmia Outcomes 40

Journal of Cardiovascular Electrophysiology

MARCH 27, 2025

ABSTRACT Background Ultra-low temperature cryoablation (ULTC) is a technique designed to rapidly cool cardiac tissue to extremely low temperatures, enabling the creation of ablation lesions for the treatment of atrial fibrillation (AF). Arrhythmia outcomes after repeat ablation were evaluated.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Arrhythmia Bicuspid/Mitral 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 7, 2024

Catheter ablation of atrial fibrillation in infiltrative cardiomyopathies ABSTRACT Atrial and ventricular arrhythmias are common in patients with Infiltrative heart diseases. AF is the most common arrhythmia identified in patients with amyloidosis due to cellular infiltration and atrial dilation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Cardiomyopathy Arrhythmia 40

DAIC

FEBRUARY 2, 2024

milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. million people in the United States by 2050 and 17.9 million in Europe by 2060.

Electrophysiology 101

Electrophysiology Innovation AFIB Atrial Fibrillation 101

AMS Cardiology

DECEMBER 14, 2023

Atrial fibrillation often shortened to AFib is an irregular and often rapid heart rhythm that can lead to serious health complications. This increases the pressure inside your ear and chest, which reduces some heart arrhythmias. The post How to Prevent an Atrial Fibrillation Attack appeared first on AMS Cardiology.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Blood Clot Heart Rhythm 52

HeartRhythm

NOVEMBER 5, 2024

Atrial fibrillation (AF) is the most common arrhythmia in the U.S., impacting six million Americans with numbers projected to increase to 12 million by 2030. Racial paradox difference in the incidence and prevalence of AF exists among Black and White Americans.

Atrial Fibrillation 40

Atrial Fibrillation Risk Factors Genetic predisposition Outcomes 40